Literature DB >> 22648339

Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg.

Osman Baspinar1, Ahmet Irdem, Ercan Sivasli, Derya Aydin Sahin, Metin Kilinc.   

Abstract

The transcatheter closure of patent ductus arteriosus (PDA) may cause more complications in small children. Amplatzer (St. Jude Medical, Plymouth, MN) has produces three types of devices for ductal occlusion: the Amplatzer duct occluder I (ADO I) and II (ADO II) and the recently introduced ADO II additional sizes (ADO II AS). We performed this study to determine the efficacy and complication rates in children who weigh <10 kg for the three types of devices used in our clinic. Between February 2007 and March 2012, 77 patients weighing <10 kg had their PDAs occluded with ADOs. The mean age of the patients was 0.76 ± 0.44 years (range 17 days-2 years), and their mean weight was 6.73 ± 2.05 (range 1.2-9.9) kg. In total, 54 girls (70.1 %) and 23 boys (29.9 %) with a mean pulmonary ductus diameter of 2.55 ± 1.0 (1.08-5.94) mm were included in the study. The ADO I was used in 26 patients (33.8 %); the ADO II was used in 43 patients (55.8 %); and the ADO II AS was used in 8 patients (10.4 %). The mean ages of patients with the ADO I, ADO II, and ADO II AS were 1.07 ± 0.48, 0.66 ± 0.31, and 0.28 ± 0.17 years (p < 0.05), respectively. Their mean weights were 7.86 ± 1.45, 6.50 ± 1.85, and 4.36 ± 2.49 kg (p < 0.05), respectively. Their mean narrowest ductal diameters were 3.11 ± 0.96, 2.25 ± 1.06, and 2.33 ± 1.01 mm (p < 0.05), respectively. The use of the ADO II and ADO II AS was found to be more common in type C defects. One patient with the ADO I and 5 patients with the ADO II (7.8 %) developed varying degrees of left pulmonary artery stenosis or iatrogenic aortic coarctation. In 1 patient, the ADO II AS was replaced with the ADO II due to a significant residual shunt observed during the procedure. Each of the ADOs has its own advantages and disadvantages. Although the ADO I is convenient for medium- and large-sized defects, the ADO II and ADO II AS can be used both anterogradely and retrogradely. The ADO II AS is safe and efficient to use in small infants.

Entities:  

Mesh:

Year:  2012        PMID: 22648339     DOI: 10.1007/s00246-012-0393-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  20 in total

1.  Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils.

Authors:  Alpay Celiker; Ebru Aypar; Tevfik Karagöz; Embiya Dilber; Naci Ceviz
Journal:  Catheter Cardiovasc Interv       Date:  2005-08       Impact factor: 2.692

2.  Amplatzer Duct Occluder device: a new technology for the closure of the moderate-to-large-sized patent ductus arteriosus.

Authors:  Robert H Pass
Journal:  Expert Rev Med Devices       Date:  2006-05       Impact factor: 3.166

3.  Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion.

Authors:  V Bhole; P Miller; C Mehta; O Stumper; Z Reinhardt; J V De Giovanni
Journal:  Catheter Cardiovasc Interv       Date:  2009-11-01       Impact factor: 2.692

4.  Transcatheter occlusion of patent ductus arteriosus in pre-term infants.

Authors:  Edwin Francis; Anil Kumar Singhi; Srinivas Lakshmivenkateshaiah; Raman Krishna Kumar
Journal:  JACC Cardiovasc Interv       Date:  2010-05       Impact factor: 11.195

5.  Transcatheter occlusion of the patent ductus arteriosus in infants: experimental testing of a new Amplatzer device.

Authors:  John L Bass; Neil Wilson
Journal:  Catheter Cardiovasc Interv       Date:  2013-10-23       Impact factor: 2.692

6.  Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders.

Authors:  Jozef Masura; Peter Tittel; Pavol Gavora; Tomaz Podnar
Journal:  Am Heart J       Date:  2006-03       Impact factor: 4.749

7.  Initial experience with the new Amplatzer Duct Occluder II.

Authors:  Jaspal Dua; Massimo Chessa; Luciane Piazza; Diana Negura; Angelo Micheletti; Claudio Bussadori; Gianfranco Butera; Mario Carminati
Journal:  J Invasive Cardiol       Date:  2009-08       Impact factor: 2.022

8.  Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct.

Authors:  Jonathan Forsey; Damien Kenny; Gareth Morgan; Alison Hayes; Mark Turner; Andrew Tometzki; Robin Martin
Journal:  Catheter Cardiovasc Interv       Date:  2009-10-01       Impact factor: 2.692

9.  Coil occlusion of PDA in patients younger than 1 year: risk factors for adverse events.

Authors:  Hideshi Tomita; Shigeru Uemura; Noriyuki Haneda; Takashi Soga; Takashi Matsuoka; Takashiro Nishioka; Satoshi Yazaki; Kinya Hatakeyama; Motoki Takamuro; Norihisa Horita
Journal:  J Cardiol       Date:  2009-01-04       Impact factor: 3.159

10.  Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children.

Authors:  G Butera; G De Rosa; M Chessa; L Piazza; A Delogu; A Frigiola; M Carminati
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

View more
  10 in total

1.  Transcatheter Closure of Arterial Duct in Infants < 6 kg: Amplatzer Duct Occluder Type I vs Amplatzer Duct Occluder II Additional Sizes.

Authors:  Giuseppe Santoro; Mario Giordano; Gianpiero Gaio; Maria Teresa Palladino; Giovanbattista Capozzi; Carola Iacono; Maria Giovanna Russo
Journal:  Pediatr Cardiol       Date:  2018-02-17       Impact factor: 1.655

2.  Ductal closure in infants under 6 kg including premature infants using AmplatzerTM duct occluder type two additional sizes: a single-centre experience in South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Makrexeni; Samkelo Jiyana
Journal:  Cardiovasc J Afr       Date:  2019-08-30       Impact factor: 1.167

3.  A Retrospective Study of 1,526 Cases of Transcatheter Occlusion of Patent Ductus Arteriosus.

Authors:  Mei Jin; Yong-Mei Liang; Xiao-Fang Wang; Bao-Jing Guo; Ke Zheng; Yan Gu; Zhen-Yu Lyu
Journal:  Chin Med J (Engl)       Date:  2015-09-05       Impact factor: 2.628

4.  Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience.

Authors:  Tugcin Bora Polat; Esma Türkmen
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426

5.  Cost-effectiveness analysis of devices for closure of patent ductus arteriosus.

Authors:  K M Krishnamoorthy; Arun Gopalakrishnan
Journal:  Ann Pediatr Cardiol       Date:  2018 Jan-Apr

6.  The new Occlutech® PDA occluder: Initial human experience.

Authors:  M A Elbashier Abdelbasit; Mazeni Alwi; Geetha Kandavello; Marhisham Che Mood; Hasri Samion; Ziyad M Hijazi
Journal:  Catheter Cardiovasc Interv       Date:  2015-04-02       Impact factor: 2.692

7.  Transvenous embolization of moderate to large patent ductus arteriosus in dogs using the Amplatzer vascular plug II.

Authors:  Nicolai Hildebrandt; Andreas Stosic; Estelle Henrich; Nicola Wiedemann; Gabriel Wurtinger; Matthias Schneider
Journal:  J Vet Intern Med       Date:  2021-12-16       Impact factor: 3.333

8.  Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa: cardiovascular topic.

Authors:  Lungile Pepeta; Adele Dippenaar
Journal:  Cardiovasc J Afr       Date:  2013-07       Impact factor: 1.167

9.  Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients.

Authors:  Sonia A El-Saiedi; Amal M El Sisi; Rodina Sobhy Mandour; Doaa M Abdel-Aziz; Wael A Attia
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug

10.  Patent ductus arteriosus closure using Occlutech® Duct Occluder, experience in Port Elizabeth, South Africa.

Authors:  Lungile Pepeta; Adele Greyling; Mahlubandile Fintan Nxele; Zongezile Masonwabe Makrexeni
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.